COSCIENS Biopharma annual gross margin
2016
2017
2018
2022
2023
2024
2025
COSCIENS Biopharma Gross Margin Growth & History (CSCIF)
COSCIENS Biopharma's gross margin was 35.30% for fiscal 2025.
View full COSCIENS Biopharma company overviewCOSCIENS Biopharma annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 35.30% | −14.02 pp |
| 2024 | 2024-12-31 | 49.33% | +8.20 pp |
| 2023 | 2023-12-31 | 41.13% | −17.58 pp |
| 2022 | 2022-12-31 | 58.72% | −33.46 pp |
| 2018 | 2018-12-31 | 92.17% | −7.83 pp |
| 2017 | 2017-12-31 | 100.00% | 0.00 pp |
| 2016 | 2016-12-31 | 100.00% | — |
COSCIENS Biopharma quarterly gross margin
Q2.18
Q3.18
Q2.19
Q3.19
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | 34.48% | −27.19 pp |
| Q3 2025 | 2025-09-30 | 41.87% | −9.27 pp |
| Q2 2025 | 2025-06-30 | 35.43% | +0.39 pp |
| Q1 2025 | 2025-03-31 | 29.53% | −14.41 pp |
| Q4 2024 | 2024-12-31 | 61.68% | +20.44 pp |
| Q3 2024 | 2024-09-30 | 51.15% | −6.11 pp |
| Q2 2024 | 2024-06-30 | 35.04% | −64.96 pp |
| Q1 2024 | 2024-03-31 | 43.95% | −3.99 pp |
| Q3 2023 | 2023-09-30 | 41.24% | +15.75 pp |
| Q2 2023 | 2023-06-30 | 57.26% | +74.52 pp |
| Q3 2019 | 2019-09-30 | 100.00% | — |
| Q2 2019 | 2019-06-30 | 47.94% | — |
| Q3 2018 | 2018-09-30 | 25.49% | — |
| Q2 2018 | 2018-06-30 | −17.26% | — |
COSCIENS Biopharma gross margin trends
Over the last five reported fiscal years, COSCIENS Biopharma's gross margin decreased from 100.00% to 35.30%, a change of −64.70 percentage points. The latest reported quarter, Q4 2025, shows 34.48%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review COSCIENS Biopharma filings at SEC.gov ↗